SEC Form 4 · accession 0001185945-16-000002
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael B Jebsen
Officer — CFO
Period of report
May 1, 2016
Accepted (ET)
Oct 20, 2016 · 10:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | May 1, 2016 | A | 430 | $2.72 | A | 68,409 | D |
Table II — derivative securities
No Table II lines on this filing.